About MBWorld Exim
MBWorld Exim is a Healthcare company based in Pune (India). It provides comprehensive formulation services for the biopharma industry. It operates on a B2B model. The company has 23 employees. Its Indian entity Mbworld Exim Private Limited reported revenue of ₹2.81 Cr. Its focus areas include Biopharmaceuticals, Formulation Services and Drug Development. Similar companies include Akums, Jubilant Life Sciences and Nectar Lifesciences; 2 of its 3 listed similar companies have raised funding.
Company details
MBWorld Exim provides comprehensive formulation services for the biopharma industry through providing healthcare solutions, biopharmaceuticals, formulation services, and drug development. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Pune, India
- Employees 23
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website mbworldexim.com
- Social LinkedIn X Facebook Instagram
- Legal Name Mbworld Exim Private Limited
- Date of Incorporation 04 Oct, 2016
- Jurisdiction Pune, Maharashtra, India
- Annual Revenue₹2.81 Cr
FY 2025 · +16% YoY
- Net Profit₹14.4 Lakh
FY 2025 · 5% margin
- EBITDA₹21.5 Lakh
FY 2025 · 8% margin
- Employee Count23
Associated legal entities of MBWorld Exim
MBWorld Exim operates through Mbworld Exim Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Mbworld Exim Private Limited CIN U51909PN2016PTC166678 | Active | 04 Oct 2016 | Pune, Maharashtra | ₹2.8 Cr | 23 | 3 | View details |
Board of directors of Mbworld Exim Private Limited (MBWorld Exim)
Mbworld Exim Private Limited is the primary company behind MBWorld Exim. The board of Mbworld Exim Private Limited currently have 3 directors; the longest-serving is Mahendra Sundecha Manikchand, appointed in 2016. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Mahendra Sundecha Manikchand DIN 07617834 | Director | 04 Oct 2016 | 10 yrs | Mbworld Exim Private Limited |
| Sandesh Sampatlal Khinwasara DIN 07923194 | Director | 31 Aug 2017 | 9 yrs 1 mo | Mbworld Exim Private Limited |
| Jaya Sundecha Mahendra DIN 07923181 | Director | 31 Aug 2017 | 9 yrs 1 mo | Mbworld Exim Private Limited |
Financials of MBWorld Exim
Figures of Mbworld Exim Private Limited, the primary company behind MBWorld Exim, for FY 2025. Revenue was ₹2.81 Cr (+16% year on year). Net profit was ₹14.4 Lakh (5% margin). EBITDA was ₹21.5 Lakh (8% margin). Revenue has grown at a compounded annual rate of -3% over three years and +32% over five years.
- ₹2.81 CrRevenue · FY 2025 · +16% YoY
- ₹14.4 LakhNet profit · 5% margin
- ₹21.5 LakhEBITDA · 8% margin
- ₹15 LakhPaid-up capital
- 23Employees (provident fund records)
- -3%Revenue CAGR, 3 years
- +32%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Mbworld Exim Private Limited are on its company page.
Detailed financial statements for MBWorld Exim
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to MBWorld Exim
MBWorld Exim has 3 listed similar companies in our database, 2 of them funded. They include Akums, Jubilant Life Sciences and Nectar Lifesciences.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| akums.in | 2004 | Delhi, India | $70M | 395 | CDMO focusing on spectrum of dosage forms and therapeutic segments | |
| jubl.com | 1978 | Noida, India | Company offering a suite of R&D and manufacturing services for small molecules and generics | |||
| neclife.com | 1995 | Chandigarh, India | $46.85M | 175 | Cephalosporin APIs and generic formulations are manufactured. |
Detailed similar companies of MBWorld Exim
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as MBWorld Exim (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about MBWorld Exim
MBWorld Exim is headquartered in Pune, India. It is registered at Pune, Maharashtra, India.
MBWorld Exim has 23 employees.
The primary company behind MBWorld Exim, Mbworld Exim Private Limited, reported revenue of ₹2.81 Cr for FY 2025, up 16% year on year.
MBWorld Exim provides comprehensive formulation services for the biopharma industry through providing healthcare solutions, biopharmaceuticals, formulation services, and drug development. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
MBWorld Exim's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
MBWorld Exim operates through Mbworld Exim Private Limited.
The legal entities of MBWorld Exim currently have 3 directors, including Sandesh Sampatlal Khinwasara, Mahendra Sundecha Manikchand, Jaya Sundecha Mahendra.